• Introduction
  • Efficacy
  • Safety
  • Prescribing Information
  • FAQs
  • History
  • Related Links
  • Safety

    Download Sufentanil Brochure Download Package Insert Printer Friendly Product Info


    Continuous Infusion – Sufentanil does not accumulate in the tissues.

    Sources: Anesthesiology (1991) Jan; 74(1):53-63
    Glass PSA, Pharmacology of remifentanil. European Journal of Anaesthesiology, 1995, 12(Suppl. 10):73-74

    Ventilatory Depression – Sufentanil has low impact on circulatory system, producing less ventilatory depression than Fentanyl.

    Source : Bailey PL, Streisand JB, East KA, et al. Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil. Anesth Analg 1990; 70:8-15.

    Nausea and Vomiting – Sufentanil induces less severe nausea and vomiting, while producing superior analgesic effects as compared to Fentanyl.


    Fentanyl Group

    Sufentanil Group


    0.12% ropivacaine+2ug/ml Fentanyl

    0.12% ropivacaine+0.5ug/ml Sufentanil


    basal dose:4ml/h, PCA dose: 2ml, lockout time: 20min

    Source: Yao Tong, Wu Xin-Min, Yang Shun-Wei. Postoperative PCEA with Sufentanil plus ropivacaine. Chinese Journal of Pain Medicine 2005, 11, (3)

    Extrahepatic Metabolism – Total and hepatic clearance significantly higher in patients administered Sufentanil for orthotopic liver transplantation (OLT)

    Source: Marc Raucoules, Michel Kaidomar, et al., Hepatic disposition of alfentanil and sufentanil in patients undergoing orthotopic liver transplantation. Anesth Analg 1997; 84:1019-24

    < Previous | Next >

        PUMC Pharmaceutical Co., Ltd.